[Process Optimization of PEGylating Fused Protein of LL-37 and Interferon-α2a].
Zhang. Mingjie M
Key Findings
- Optimal PEGylation uses 5 kDa PEG, protein at 0.6 mg/mL, a 1:10 protein‑to‑PEG ratio, 4 °C temperature, and pH 8.8
- The process yields about 87% PEG‑modified protein in repeat experiments
- After PEGylation, the interferon activity stays above 58% and antimicrobial activity stays above 97%
Practical Outcomes
- If you can produce the LL‑37/IFN‑α2a fusion protein, following these conditions will give you a longer‑lasting version with most of its beneficial effects intact. This protocol is useful for labs or advanced DIY setups aiming to create more stable peptide therapeutics, though it requires standard protein‑chemistry equipment.
Summary
Researchers figured out the best way to attach a PEG molecule to a combined LL‑37 and interferon‑α2a protein, which makes the protein stay in the body longer and reduces immune reactions while keeping most of its original activity.
Abstract
PEGylating is an effective way for prolonging the half-time period and decreasing the immunogenicity of protein drugs. With experiments of single factor, it was proved that the optimal processes for PEGylating the fused protein of LL-37 and interferon (IFN)-α2a were: PEG molecular weight was 5,000, fused protein concentration was 0.6 mg/mL, the mole ratio of protein to mPEG₅₀₀₀-SS was 1:10, the reaction temperature was 4 °C, and the pH was 9.0, respectively. With orthogonal experiments, we proved that the influential order of 3 main factors is: the fused protein concentration > the mole ratio of protein and mPEG₅₀₀₀-SS > pH and the optimal conditions were the fused protein concentration as 0.6 mg/mL, the mole ratio of protein and mPEG₅₀₀₀-SS as 1:10, pH as 8.8. Under these optimal conditions, the average rate of PEGylated protein with 3 times parallel experiments was 86.98%. After PEGylated, the interferon activity and antimicrobial activity of fused protein could be remained higher than 58% and 97%, respectively.
Study Information
pubmed
2015